Intravenous Thyroxine for Heart-Eligible Organ Donors

Completed · Phase 3 · Has a placebo group

Conditions studied: Brain Death, Heart Failure

In brief

This randomized controlled trial will evaluate whether intravenous thyroxine infusion given to brain-dead organ donors who are eligible to donate hearts for 12 hours will result in more hearts transplanted than saline placebo

Key facts

Study ID
NCT04415658
Run by
Washington University School of Medicine
People needed
838
Starts
2020-12-01
Expected to finish
2022-12-06
Last updated by the study team
2024-01-10

Who can join

Age: 14 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.